Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989 Feb;57(2):582-9.
doi: 10.1128/iai.57.2.582-589.1989.

Accessibility of gonococcal and meningococcal surface antigens: immunogold labeling for quantitative electron microscopy

Affiliations

Accessibility of gonococcal and meningococcal surface antigens: immunogold labeling for quantitative electron microscopy

M Pâques et al. Infect Immun. 1989 Feb.

Abstract

The parallel application of two electron microscopic immunogold labeling procedures was used to assess the surface exposure and accessibility of gonococcal and meningococcal surface antigens. Monoclonal antibodies were used as markers for the surface antigens, i.e., outer membrane proteins and lipooligosaccharides. To evaluate the labeling densities obtained after incubation of whole bacteria in suspension or ultrathin cryosections of bacteria, a method of electron microscopic quantitation was developed. Incubation of whole bacterial suspensions with monoclonal antibodies and protein A-gold resulted in specific labeling of the bacterial surfaces. However, the labeling densities varied largely in each cell. By contrast, cryosections showed uniform heavy labeling densities at the surface of the outer membranes of all cells. Apparently, by sectioning the cells the antigen-masking barrier could be evaded, and steric hindrance was no longer restrictive. Thus, a better estimate of both the presence and the surface exposure, i.e., the accessibility of antigens, could be made. Such information is essential for us to better understand host-bacterial interactions and to develop new vaccines.

PubMed Disclaimer

References

    1. J Bacteriol. 1988 Mar;170(3):1063-8 - PubMed
    1. Rev Infect Dis. 1985 Jul-Aug;7(4):504-10 - PubMed
    1. Antonie Van Leeuwenhoek. 1987;53(6):413-9 - PubMed
    1. J Gen Microbiol. 1988 Mar;134(3):539-45 - PubMed
    1. Microb Pathog. 1988 Jan;4(1):27-32 - PubMed

MeSH terms

LinkOut - more resources